| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Twins | 44 | 2024 | 52 | 5.010 |
Why?
|
| Aging | 53 | 2026 | 784 | 4.740 |
Why?
|
| Twins, Monozygotic | 51 | 2025 | 73 | 4.450 |
Why?
|
| Twins, Dizygotic | 48 | 2025 | 57 | 4.330 |
Why?
|
| Cognition | 44 | 2026 | 514 | 4.240 |
Why?
|
| Diseases in Twins | 35 | 2025 | 56 | 4.200 |
Why?
|
| Cognitive Dysfunction | 24 | 2026 | 360 | 3.350 |
Why?
|
| Gene-Environment Interaction | 21 | 2026 | 54 | 3.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 27 | 2026 | 406 | 2.860 |
Why?
|
| Intellectual Disability | 15 | 2025 | 177 | 2.770 |
Why?
|
| Alzheimer Disease | 23 | 2026 | 773 | 2.370 |
Why?
|
| Phenotype | 53 | 2025 | 1236 | 2.300 |
Why?
|
| Neuropsychological Tests | 32 | 2025 | 420 | 2.240 |
Why?
|
| Male | 226 | 2026 | 31403 | 2.180 |
Why?
|
| Cerebral Cortex | 18 | 2025 | 276 | 1.900 |
Why?
|
| Environment | 25 | 2020 | 125 | 1.860 |
Why?
|
| Executive Function | 16 | 2026 | 71 | 1.860 |
Why?
|
| Neurodevelopmental Disorders | 9 | 2023 | 50 | 1.860 |
Why?
|
| Middle Aged | 164 | 2026 | 18498 | 1.850 |
Why?
|
| Brain | 36 | 2026 | 1672 | 1.830 |
Why?
|
| Registries | 32 | 2025 | 935 | 1.800 |
Why?
|
| Humans | 263 | 2026 | 65830 | 1.760 |
Why?
|
| Cognition Disorders | 14 | 2019 | 224 | 1.730 |
Why?
|
| Genetic Predisposition to Disease | 30 | 2025 | 737 | 1.680 |
Why?
|
| Longitudinal Studies | 40 | 2025 | 1291 | 1.610 |
Why?
|
| Magnetic Resonance Imaging | 46 | 2026 | 2324 | 1.510 |
Why?
|
| Memory, Episodic | 12 | 2026 | 21 | 1.500 |
Why?
|
| White Matter | 15 | 2026 | 138 | 1.430 |
Why?
|
| Developmental Disabilities | 7 | 2023 | 119 | 1.410 |
Why?
|
| Chromosome Deletion | 5 | 2023 | 42 | 1.270 |
Why?
|
| Vietnam Conflict | 22 | 2025 | 26 | 1.260 |
Why?
|
| Erectile Dysfunction | 3 | 2023 | 28 | 1.260 |
Why?
|
| Body Mass Index | 14 | 2026 | 901 | 1.170 |
Why?
|
| Veterans | 34 | 2021 | 770 | 1.130 |
Why?
|
| Hippocampus | 10 | 2026 | 277 | 1.050 |
Why?
|
| Hypertension | 9 | 2023 | 618 | 1.030 |
Why?
|
| Aged | 67 | 2026 | 15145 | 0.970 |
Why?
|
| Depression | 15 | 2025 | 910 | 0.970 |
Why?
|
| Adult | 86 | 2026 | 17575 | 0.970 |
Why?
|
| Twin Studies as Topic | 12 | 2021 | 14 | 0.960 |
Why?
|
| Social Environment | 10 | 2012 | 93 | 0.950 |
Why?
|
| Hand Deformities, Congenital | 1 | 2025 | 5 | 0.930 |
Why?
|
| Mutation | 13 | 2025 | 2675 | 0.930 |
Why?
|
| Cryptorchidism | 1 | 2025 | 20 | 0.910 |
Why?
|
| Growth Disorders | 1 | 2025 | 31 | 0.910 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 877 | 0.850 |
Why?
|
| Autistic Disorder | 3 | 2025 | 160 | 0.850 |
Why?
|
| Memory, Short-Term | 6 | 2022 | 67 | 0.840 |
Why?
|
| Child | 32 | 2025 | 4651 | 0.830 |
Why?
|
| Genetics, Behavioral | 5 | 2013 | 10 | 0.820 |
Why?
|
| Metabolic Syndrome | 2 | 2022 | 147 | 0.770 |
Why?
|
| Megalencephaly | 3 | 2022 | 5 | 0.760 |
Why?
|
| Cognitive Reserve | 5 | 2026 | 9 | 0.760 |
Why?
|
| Young Adult | 33 | 2026 | 4882 | 0.760 |
Why?
|
| Biomarkers | 11 | 2026 | 1502 | 0.760 |
Why?
|
| Risk Factors | 34 | 2025 | 5475 | 0.740 |
Why?
|
| Genotype | 13 | 2024 | 676 | 0.730 |
Why?
|
| Female | 71 | 2026 | 34420 | 0.730 |
Why?
|
| Apolipoproteins E | 6 | 2024 | 116 | 0.720 |
Why?
|
| Child, Preschool | 18 | 2025 | 2089 | 0.710 |
Why?
|
| Neural Tube Defects | 1 | 2022 | 28 | 0.710 |
Why?
|
| Spinal Dysraphism | 1 | 2022 | 18 | 0.710 |
Why?
|
| Hydrocortisone | 9 | 2018 | 192 | 0.700 |
Why?
|
| Independent Living | 5 | 2026 | 55 | 0.700 |
Why?
|
| Pedigree | 6 | 2021 | 193 | 0.690 |
Why?
|
| Sleep | 3 | 2021 | 246 | 0.680 |
Why?
|
| Genome-Wide Association Study | 11 | 2024 | 366 | 0.670 |
Why?
|
| Circadian Rhythm | 6 | 2014 | 364 | 0.660 |
Why?
|
| Combat Disorders | 6 | 2013 | 11 | 0.660 |
Why?
|
| Body Height | 5 | 2020 | 66 | 0.640 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 134 | 0.640 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2021 | 29 | 0.640 |
Why?
|
| Hypercholesterolemia | 1 | 2021 | 75 | 0.630 |
Why?
|
| Adolescent | 32 | 2025 | 6367 | 0.610 |
Why?
|
| Alcoholism | 8 | 2008 | 329 | 0.590 |
Why?
|
| Mutation, Missense | 6 | 2024 | 190 | 0.590 |
Why?
|
| Aptitude | 3 | 2019 | 10 | 0.580 |
Why?
|
| Locus Coeruleus | 5 | 2024 | 24 | 0.580 |
Why?
|
| Quantitative Trait, Heritable | 8 | 2020 | 28 | 0.570 |
Why?
|
| Abnormalities, Multiple | 3 | 2016 | 54 | 0.570 |
Why?
|
| Autism Spectrum Disorder | 2 | 2021 | 181 | 0.570 |
Why?
|
| Surveys and Questionnaires | 12 | 2025 | 2790 | 0.560 |
Why?
|
| Amyloid beta-Peptides | 7 | 2026 | 323 | 0.560 |
Why?
|
| Individuality | 3 | 2017 | 24 | 0.560 |
Why?
|
| Testosterone | 5 | 2020 | 128 | 0.550 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 9 | 0.550 |
Why?
|
| tau Proteins | 6 | 2026 | 215 | 0.550 |
Why?
|
| Minocycline | 1 | 2018 | 28 | 0.550 |
Why?
|
| Chronic Pain | 3 | 2025 | 157 | 0.540 |
Why?
|
| Meningomyelocele | 1 | 2017 | 10 | 0.540 |
Why?
|
| Neurofilament Proteins | 4 | 2026 | 26 | 0.530 |
Why?
|
| Age Factors | 13 | 2025 | 1595 | 0.530 |
Why?
|
| Panic Disorder | 2 | 2011 | 32 | 0.530 |
Why?
|
| Models, Genetic | 12 | 2019 | 267 | 0.530 |
Why?
|
| Genes, Dominant | 2 | 2021 | 56 | 0.530 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 55 | 0.530 |
Why?
|
| Reaction Time | 4 | 2019 | 134 | 0.520 |
Why?
|
| Infant | 14 | 2023 | 1718 | 0.520 |
Why?
|
| Statistics as Topic | 4 | 2013 | 147 | 0.510 |
Why?
|
| Genetic Variation | 8 | 2024 | 395 | 0.500 |
Why?
|
| Neuroimaging | 5 | 2025 | 170 | 0.490 |
Why?
|
| Arousal | 3 | 2015 | 42 | 0.490 |
Why?
|
| Dwarfism | 1 | 2016 | 16 | 0.490 |
Why?
|
| Diffusion Tensor Imaging | 8 | 2026 | 81 | 0.490 |
Why?
|
| Memory | 6 | 2025 | 124 | 0.470 |
Why?
|
| Cognitive Aging | 3 | 2022 | 4 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2014 | 24 | 0.460 |
Why?
|
| Neurodegenerative Diseases | 3 | 2024 | 152 | 0.460 |
Why?
|
| Antisocial Personality Disorder | 6 | 2019 | 38 | 0.460 |
Why?
|
| Obesity | 5 | 2026 | 1281 | 0.460 |
Why?
|
| Residence Characteristics | 3 | 2026 | 230 | 0.450 |
Why?
|
| C-Reactive Protein | 3 | 2026 | 171 | 0.450 |
Why?
|
| Parents | 3 | 2020 | 418 | 0.450 |
Why?
|
| Smoking | 8 | 2022 | 864 | 0.440 |
Why?
|
| Educational Status | 6 | 2026 | 279 | 0.440 |
Why?
|
| Vietnam | 13 | 2022 | 191 | 0.440 |
Why?
|
| Tobacco Use Disorder | 7 | 2015 | 248 | 0.430 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2014 | 7 | 0.430 |
Why?
|
| Chromosome Duplication | 1 | 2014 | 3 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 23 | 0.430 |
Why?
|
| Sexual Partners | 2 | 2026 | 76 | 0.430 |
Why?
|
| Language Disorders | 1 | 2014 | 25 | 0.420 |
Why?
|
| Brain Mapping | 10 | 2018 | 247 | 0.420 |
Why?
|
| Spirituality | 2 | 2007 | 44 | 0.420 |
Why?
|
| Organ Size | 13 | 2024 | 175 | 0.420 |
Why?
|
| Leukoencephalopathies | 3 | 2021 | 25 | 0.420 |
Why?
|
| Alcohol Drinking | 9 | 2022 | 325 | 0.420 |
Why?
|
| Blepharophimosis | 1 | 2014 | 2 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 12 | 0.410 |
Why?
|
| Skin Abnormalities | 1 | 2014 | 8 | 0.410 |
Why?
|
| Cohort Studies | 20 | 2026 | 2651 | 0.410 |
Why?
|
| Apolipoprotein E4 | 5 | 2022 | 48 | 0.410 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1226 | 0.410 |
Why?
|
| Microcephaly | 1 | 2014 | 15 | 0.410 |
Why?
|
| Life Change Events | 4 | 2018 | 66 | 0.410 |
Why?
|
| Early Diagnosis | 6 | 2020 | 95 | 0.410 |
Why?
|
| Mental Recall | 6 | 2021 | 95 | 0.390 |
Why?
|
| Interpersonal Relations | 4 | 2026 | 161 | 0.390 |
Why?
|
| Alleles | 6 | 2019 | 455 | 0.380 |
Why?
|
| Genetic Association Studies | 7 | 2019 | 120 | 0.380 |
Why?
|
| Facies | 3 | 2025 | 10 | 0.380 |
Why?
|
| Frailty | 2 | 2026 | 132 | 0.380 |
Why?
|
| Gray Matter | 5 | 2026 | 43 | 0.380 |
Why?
|
| United States | 27 | 2026 | 8186 | 0.370 |
Why?
|
| Memory Disorders | 4 | 2025 | 53 | 0.370 |
Why?
|
| Semantics | 2 | 2020 | 58 | 0.370 |
Why?
|
| Verbal Learning | 3 | 2013 | 21 | 0.370 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 5 | 0.370 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 12 | 0.370 |
Why?
|
| Comorbidity | 16 | 2016 | 1122 | 0.360 |
Why?
|
| Trisomy | 1 | 2012 | 22 | 0.360 |
Why?
|
| Self Report | 3 | 2025 | 395 | 0.360 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 74 | 0.360 |
Why?
|
| Language Development Disorders | 2 | 2022 | 26 | 0.360 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2011 | 1 | 0.360 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 2 | 0.360 |
Why?
|
| Genes, Duplicate | 1 | 2011 | 2 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 808 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2025 | 715 | 0.350 |
Why?
|
| Mental Disorders | 10 | 2020 | 827 | 0.350 |
Why?
|
| Feedback, Psychological | 1 | 2011 | 15 | 0.340 |
Why?
|
| Object Attachment | 2 | 2026 | 19 | 0.340 |
Why?
|
| Space Perception | 1 | 2011 | 20 | 0.340 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 116 | 0.340 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1336 | 0.320 |
Why?
|
| Verbal Behavior | 3 | 2020 | 36 | 0.320 |
Why?
|
| Myotonia Congenita | 1 | 2010 | 2 | 0.320 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2025 | 97 | 0.320 |
Why?
|
| Carbamazepine | 1 | 2010 | 10 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2011 | 382 | 0.320 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 69 | 0.320 |
Why?
|
| Chloride Channels | 1 | 2010 | 28 | 0.310 |
Why?
|
| Amygdala | 3 | 2026 | 85 | 0.310 |
Why?
|
| DNA Copy Number Variations | 3 | 2022 | 73 | 0.310 |
Why?
|
| Transcription Factors | 2 | 2022 | 1561 | 0.300 |
Why?
|
| Urogenital Abnormalities | 2 | 2023 | 12 | 0.300 |
Why?
|
| Zebrafish | 5 | 2025 | 374 | 0.300 |
Why?
|
| Microarray Analysis | 3 | 2014 | 65 | 0.290 |
Why?
|
| Anxiety | 4 | 2026 | 427 | 0.290 |
Why?
|
| Weight Gain | 2 | 2025 | 165 | 0.290 |
Why?
|
| DNA Methylation | 2 | 2022 | 307 | 0.290 |
Why?
|
| Health Status | 4 | 2012 | 448 | 0.290 |
Why?
|
| Disease Progression | 9 | 2021 | 1229 | 0.280 |
Why?
|
| Body Weight | 3 | 2017 | 377 | 0.280 |
Why?
|
| Loss of Function Mutation | 2 | 2025 | 23 | 0.270 |
Why?
|
| Models, Psychological | 7 | 2011 | 102 | 0.270 |
Why?
|
| alpha-Mannosidosis | 1 | 2007 | 1 | 0.270 |
Why?
|
| Blood Pressure | 5 | 2023 | 537 | 0.270 |
Why?
|
| Nicotine | 3 | 2005 | 118 | 0.270 |
Why?
|
| Haploinsufficiency | 3 | 2023 | 21 | 0.260 |
Why?
|
| Smoking Cessation | 6 | 2022 | 553 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 428 | 0.260 |
Why?
|
| Pupil | 2 | 2017 | 9 | 0.260 |
Why?
|
| Models, Statistical | 9 | 2021 | 312 | 0.260 |
Why?
|
| Family Health | 2 | 2008 | 68 | 0.260 |
Why?
|
| Infant, Newborn | 4 | 2021 | 1438 | 0.260 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 38 | 0.260 |
Why?
|
| Nerve Net | 2 | 2019 | 105 | 0.250 |
Why?
|
| Saliva | 9 | 2018 | 100 | 0.250 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 35 | 0.250 |
Why?
|
| Meta-Analysis as Topic | 2 | 2025 | 78 | 0.250 |
Why?
|
| Time Factors | 10 | 2015 | 3777 | 0.250 |
Why?
|
| Ganglionic Stimulants | 2 | 2005 | 6 | 0.250 |
Why?
|
| Behavior | 2 | 2021 | 36 | 0.240 |
Why?
|
| Quality of Life | 6 | 2025 | 1266 | 0.240 |
Why?
|
| Dyslexia | 1 | 2005 | 7 | 0.230 |
Why?
|
| Affect | 2 | 2025 | 132 | 0.230 |
Why?
|
| Educational Measurement | 1 | 2007 | 214 | 0.230 |
Why?
|
| Presbycusis | 1 | 2025 | 5 | 0.220 |
Why?
|
| Language | 2 | 2019 | 155 | 0.220 |
Why?
|
| Environmental Exposure | 4 | 2023 | 228 | 0.220 |
Why?
|
| Urban Population | 1 | 2026 | 201 | 0.220 |
Why?
|
| Overweight | 1 | 2007 | 254 | 0.220 |
Why?
|
| Ataxia | 1 | 2025 | 21 | 0.220 |
Why?
|
| Hearing | 1 | 2025 | 31 | 0.220 |
Why?
|
| Aged, 80 and over | 9 | 2026 | 5681 | 0.220 |
Why?
|
| Prevalence | 13 | 2017 | 1453 | 0.220 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 69 | 0.210 |
Why?
|
| Family | 3 | 2020 | 250 | 0.210 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 162 | 0.210 |
Why?
|
| Galvanic Skin Response | 1 | 2004 | 25 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2026 | 172 | 0.210 |
Why?
|
| Coitus | 1 | 2004 | 15 | 0.210 |
Why?
|
| Education | 2 | 2019 | 66 | 0.210 |
Why?
|
| Exome | 3 | 2022 | 69 | 0.210 |
Why?
|
| Homosexuality, Male | 1 | 2004 | 29 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2024 | 518 | 0.210 |
Why?
|
| Agoraphobia | 1 | 2004 | 11 | 0.210 |
Why?
|
| Schizophrenia | 2 | 2006 | 279 | 0.200 |
Why?
|
| California | 3 | 2013 | 178 | 0.200 |
Why?
|
| Risk | 7 | 2019 | 375 | 0.200 |
Why?
|
| Severity of Illness Index | 6 | 2015 | 1569 | 0.200 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2023 | 14 | 0.200 |
Why?
|
| Genetic Loci | 2 | 2024 | 117 | 0.200 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2023 | 22 | 0.200 |
Why?
|
| Dementia | 3 | 2023 | 290 | 0.200 |
Why?
|
| Heroin Dependence | 3 | 2008 | 21 | 0.190 |
Why?
|
| Cerebellum | 1 | 2024 | 94 | 0.190 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 121 | 0.190 |
Why?
|
| Cutis Laxa | 1 | 2023 | 8 | 0.190 |
Why?
|
| Forced Expiratory Volume | 2 | 2014 | 213 | 0.190 |
Why?
|
| Intermediate Filaments | 1 | 2022 | 10 | 0.190 |
Why?
|
| Analysis of Variance | 5 | 2014 | 606 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 160 | 0.190 |
Why?
|
| Life Style | 3 | 2021 | 324 | 0.190 |
Why?
|
| RNA Splicing | 2 | 2021 | 173 | 0.190 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 12 | 0.190 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 233 | 0.190 |
Why?
|
| Exercise | 2 | 2026 | 970 | 0.190 |
Why?
|
| Prospective Studies | 5 | 2026 | 3339 | 0.190 |
Why?
|
| Retinal Dystrophies | 1 | 2022 | 4 | 0.190 |
Why?
|
| Peptide Fragments | 4 | 2026 | 419 | 0.180 |
Why?
|
| Air Pollution | 1 | 2023 | 42 | 0.180 |
Why?
|
| Conduct Disorder | 3 | 2007 | 24 | 0.180 |
Why?
|
| Retinitis Pigmentosa | 1 | 2022 | 26 | 0.180 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2022 | 5 | 0.180 |
Why?
|
| Connective Tissue Diseases | 1 | 2022 | 11 | 0.180 |
Why?
|
| Zebrafish Proteins | 2 | 2020 | 171 | 0.180 |
Why?
|
| Inheritance Patterns | 5 | 2018 | 21 | 0.180 |
Why?
|
| Tauopathies | 1 | 2022 | 17 | 0.180 |
Why?
|
| Software | 1 | 2025 | 401 | 0.180 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2022 | 23 | 0.180 |
Why?
|
| Encephalocele | 1 | 2022 | 14 | 0.180 |
Why?
|
| Amino Acids | 1 | 2023 | 148 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2023 | 178 | 0.180 |
Why?
|
| Health Surveys | 4 | 2013 | 319 | 0.180 |
Why?
|
| Cross-Sectional Studies | 9 | 2025 | 2739 | 0.170 |
Why?
|
| Academic Success | 2 | 2020 | 12 | 0.170 |
Why?
|
| Genes | 2 | 2012 | 90 | 0.170 |
Why?
|
| Air Pollutants | 1 | 2023 | 100 | 0.170 |
Why?
|
| Anisotropy | 5 | 2019 | 63 | 0.170 |
Why?
|
| Down Syndrome | 1 | 2022 | 45 | 0.170 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 5 | 0.170 |
Why?
|
| Sickness Impact Profile | 2 | 2015 | 46 | 0.170 |
Why?
|
| Case-Control Studies | 5 | 2026 | 1146 | 0.170 |
Why?
|
| Healthy Lifestyle | 1 | 2021 | 28 | 0.170 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2021 | 1 | 0.170 |
Why?
|
| Regression Analysis | 3 | 2013 | 498 | 0.170 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2007 | 119 | 0.170 |
Why?
|
| Epilepsy | 2 | 2021 | 113 | 0.170 |
Why?
|
| Infratentorial Neoplasms | 1 | 2021 | 4 | 0.170 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 3 | 0.170 |
Why?
|
| Photic Stimulation | 2 | 2014 | 89 | 0.170 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 56 | 0.170 |
Why?
|
| Substance-Related Disorders | 6 | 2010 | 758 | 0.170 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 932 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2021 | 59 | 0.160 |
Why?
|
| Sarcoma | 1 | 2021 | 36 | 0.160 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 113 | 0.160 |
Why?
|
| Marijuana Abuse | 4 | 2005 | 24 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 50 | 0.160 |
Why?
|
| Transcriptome | 1 | 2024 | 408 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2022 | 162 | 0.160 |
Why?
|
| Genetic Background | 1 | 2020 | 7 | 0.160 |
Why?
|
| Heterozygote | 3 | 2019 | 175 | 0.160 |
Why?
|
| Seizures | 1 | 2021 | 141 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 532 | 0.160 |
Why?
|
| Spliceosomes | 1 | 2020 | 44 | 0.160 |
Why?
|
| Chromosome Aberrations | 2 | 2022 | 70 | 0.160 |
Why?
|
| Recurrence | 1 | 2022 | 665 | 0.150 |
Why?
|
| Genetic Testing | 2 | 2018 | 144 | 0.150 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 88 | 0.150 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 14 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 238 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2019 | 7 | 0.150 |
Why?
|
| Personal Satisfaction | 2 | 2012 | 83 | 0.150 |
Why?
|
| Prefrontal Cortex | 2 | 2010 | 129 | 0.150 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 30 | 0.150 |
Why?
|
| DNA Helicases | 1 | 2021 | 202 | 0.150 |
Why?
|
| Parenting | 1 | 2020 | 79 | 0.150 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 558 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 173 | 0.140 |
Why?
|
| Spasms, Infantile | 1 | 2018 | 2 | 0.140 |
Why?
|
| Rest | 1 | 2019 | 51 | 0.140 |
Why?
|
| Calcium Channels, R-Type | 1 | 2018 | 2 | 0.140 |
Why?
|
| Contracture | 1 | 2018 | 9 | 0.140 |
Why?
|
| Dyskinesias | 1 | 2018 | 9 | 0.140 |
Why?
|
| Social Class | 4 | 2018 | 137 | 0.140 |
Why?
|
| Cation Transport Proteins | 1 | 2018 | 23 | 0.140 |
Why?
|
| Bunion | 1 | 2018 | 1 | 0.140 |
Why?
|
| Emotions | 2 | 2011 | 236 | 0.140 |
Why?
|
| Ankle Fractures | 1 | 2018 | 12 | 0.140 |
Why?
|
| Antihypertensive Agents | 3 | 2015 | 183 | 0.140 |
Why?
|
| Coronary Disease | 1 | 2019 | 247 | 0.140 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2015 | 21 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 59 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 229 | 0.130 |
Why?
|
| Personality Inventory | 3 | 2012 | 56 | 0.130 |
Why?
|
| Sex Factors | 5 | 2019 | 995 | 0.130 |
Why?
|
| Exons | 1 | 2018 | 208 | 0.130 |
Why?
|
| Human Development | 1 | 2017 | 9 | 0.130 |
Why?
|
| Genetic Linkage | 2 | 2008 | 97 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 322 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 277 | 0.130 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 69 | 0.130 |
Why?
|
| Histones | 1 | 2020 | 497 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 265 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2017 | 39 | 0.130 |
Why?
|
| Mental Health | 2 | 2012 | 363 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2016 | 42 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2018 | 30 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 446 | 0.120 |
Why?
|
| Models, Neurological | 1 | 2017 | 83 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 411 | 0.120 |
Why?
|
| Functional Laterality | 2 | 2013 | 141 | 0.120 |
Why?
|
| Intelligence | 1 | 2016 | 51 | 0.120 |
Why?
|
| Databases, Factual | 3 | 2015 | 888 | 0.110 |
Why?
|
| Ulna | 1 | 2015 | 5 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2015 | 5 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2015 | 17 | 0.110 |
Why?
|
| Fibula | 1 | 2015 | 10 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 663 | 0.110 |
Why?
|
| Radius | 1 | 2015 | 20 | 0.110 |
Why?
|
| Osteochondrodysplasias | 1 | 2015 | 12 | 0.110 |
Why?
|
| Anthropometry | 1 | 2015 | 86 | 0.110 |
Why?
|
| Leg | 1 | 2015 | 87 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2023 | 6955 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2015 | 115 | 0.110 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2014 | 3 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2014 | 2115 | 0.110 |
Why?
|
| Tibia | 1 | 2015 | 76 | 0.110 |
Why?
|
| Boston | 1 | 2015 | 259 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2014 | 26 | 0.110 |
Why?
|
| Age of Onset | 3 | 2021 | 174 | 0.110 |
Why?
|
| Attention | 3 | 2017 | 154 | 0.110 |
Why?
|
| Language Tests | 1 | 2014 | 39 | 0.110 |
Why?
|
| Depressive Disorder | 2 | 2010 | 284 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 316 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2014 | 120 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 9 | 0.100 |
Why?
|
| Mental Competency | 1 | 2014 | 63 | 0.100 |
Why?
|
| Syndrome | 3 | 2022 | 182 | 0.100 |
Why?
|
| Stress, Psychological | 4 | 2026 | 475 | 0.100 |
Why?
|
| Cerebrum | 1 | 2013 | 16 | 0.100 |
Why?
|
| Cocaine-Related Disorders | 2 | 2005 | 81 | 0.100 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 65 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 161 | 0.100 |
Why?
|
| Genetic Phenomena | 1 | 2013 | 1 | 0.100 |
Why?
|
| Radiography | 2 | 2013 | 559 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 178 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2017 | 719 | 0.100 |
Why?
|
| Gulf War | 3 | 2009 | 5 | 0.090 |
Why?
|
| Vital Capacity | 1 | 2013 | 123 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2012 | 11 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2005 | 126 | 0.090 |
Why?
|
| Adiposity | 3 | 2019 | 89 | 0.090 |
Why?
|
| Sex Chromosomes | 1 | 2012 | 12 | 0.090 |
Why?
|
| Connectome | 2 | 2026 | 42 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 95 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 745 | 0.090 |
Why?
|
| Research Design | 3 | 2015 | 589 | 0.090 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2011 | 14 | 0.090 |
Why?
|
| Animals | 8 | 2025 | 21492 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 82 | 0.090 |
Why?
|
| Signal Detection, Psychological | 1 | 2011 | 2 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 197 | 0.090 |
Why?
|
| Self Concept | 1 | 2012 | 123 | 0.090 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2011 | 13 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2011 | 35 | 0.080 |
Why?
|
| Facial Expression | 1 | 2010 | 16 | 0.080 |
Why?
|
| Cultural Characteristics | 1 | 2010 | 38 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2500 | 0.080 |
Why?
|
| Cues | 1 | 2011 | 81 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2005 | 251 | 0.080 |
Why?
|
| Water | 2 | 2022 | 323 | 0.080 |
Why?
|
| Dominance-Subordination | 1 | 2010 | 2 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2011 | 63 | 0.080 |
Why?
|
| Kidney | 2 | 2023 | 460 | 0.080 |
Why?
|
| Spouses | 2 | 2011 | 40 | 0.080 |
Why?
|
| Logistic Models | 6 | 2017 | 1274 | 0.080 |
Why?
|
| Jet Lag Syndrome | 1 | 2010 | 4 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2007 | 237 | 0.080 |
Why?
|
| Cerebral Ventricles | 1 | 2010 | 29 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2010 | 51 | 0.080 |
Why?
|
| Genome | 2 | 2022 | 286 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2011 | 76 | 0.080 |
Why?
|
| Mediator Complex | 1 | 2009 | 13 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 11 | 0.080 |
Why?
|
| Travel | 1 | 2010 | 44 | 0.080 |
Why?
|
| Causality | 2 | 2006 | 60 | 0.080 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 47 | 0.080 |
Why?
|
| Mental Processes | 1 | 2009 | 18 | 0.080 |
Why?
|
| Linear Models | 3 | 2015 | 405 | 0.070 |
Why?
|
| North America | 2 | 2020 | 114 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 793 | 0.070 |
Why?
|
| Video Games | 1 | 2008 | 12 | 0.070 |
Why?
|
| Problem Solving | 1 | 2008 | 32 | 0.070 |
Why?
|
| Australia | 2 | 2020 | 131 | 0.070 |
Why?
|
| Self Disclosure | 1 | 2008 | 37 | 0.070 |
Why?
|
| Europe | 2 | 2020 | 200 | 0.070 |
Why?
|
| Inflammation | 2 | 2026 | 1198 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1060 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2010 | 201 | 0.070 |
Why?
|
| Military Personnel | 3 | 2005 | 111 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2008 | 129 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 3 | 2018 | 103 | 0.070 |
Why?
|
| Muscle Hypotonia | 1 | 2007 | 8 | 0.070 |
Why?
|
| Basal Ganglia Diseases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Existentialism | 1 | 2007 | 1 | 0.070 |
Why?
|
| Contrast Sensitivity | 1 | 2007 | 2 | 0.070 |
Why?
|
| Environmental Health | 1 | 2007 | 14 | 0.070 |
Why?
|
| Odds Ratio | 3 | 2004 | 757 | 0.070 |
Why?
|
| North Carolina | 1 | 2007 | 69 | 0.070 |
Why?
|
| Proof of Concept Study | 2 | 2018 | 39 | 0.060 |
Why?
|
| Religion and Medicine | 1 | 2007 | 20 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 297 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2007 | 13 | 0.060 |
Why?
|
| Warfare | 2 | 2005 | 42 | 0.060 |
Why?
|
| Atrophy | 2 | 2019 | 89 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2026 | 42 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 3 | 2011 | 59 | 0.060 |
Why?
|
| Trail Making Test | 2 | 2019 | 6 | 0.060 |
Why?
|
| Reading | 1 | 2007 | 95 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2011 | 86 | 0.060 |
Why?
|
| Neurons | 1 | 2012 | 935 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2026 | 105 | 0.060 |
Why?
|
| Persian Gulf Syndrome | 1 | 2005 | 2 | 0.060 |
Why?
|
| Forecasting | 2 | 2018 | 231 | 0.060 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2025 | 27 | 0.060 |
Why?
|
| Psychometrics | 1 | 2007 | 396 | 0.060 |
Why?
|
| Auditory Threshold | 1 | 2025 | 30 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2005 | 18 | 0.050 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2004 | 4 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2020 | 199 | 0.050 |
Why?
|
| Intelligence Tests | 2 | 2014 | 26 | 0.050 |
Why?
|
| Genome, Human | 1 | 2006 | 238 | 0.050 |
Why?
|
| Rural Population | 1 | 2026 | 225 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 126 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2023 | 6 | 0.050 |
Why?
|
| Protein Phosphatase 2C | 1 | 2023 | 3 | 0.050 |
Why?
|
| Protective Factors | 1 | 2023 | 33 | 0.050 |
Why?
|
| Penile Erection | 1 | 2023 | 7 | 0.050 |
Why?
|
| Orgasm | 1 | 2023 | 3 | 0.050 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2003 | 11 | 0.050 |
Why?
|
| Ornithine | 1 | 2023 | 24 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2023 | 9 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 162 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2022 | 16 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 17 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 46 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Face | 1 | 2022 | 36 | 0.050 |
Why?
|
| South Carolina | 1 | 2022 | 16 | 0.050 |
Why?
|
| Usher Syndromes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 746 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2022 | 30 | 0.050 |
Why?
|
| Computational Biology | 2 | 2019 | 369 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 66 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 136 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2023 | 105 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 38 | 0.050 |
Why?
|
| Review Literature as Topic | 1 | 2022 | 41 | 0.050 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2022 | 8 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 72 | 0.050 |
Why?
|
| Personality Disorders | 1 | 2002 | 20 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 227 | 0.050 |
Why?
|
| Vomiting | 1 | 2023 | 139 | 0.040 |
Why?
|
| Siblings | 2 | 2015 | 41 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2022 | 106 | 0.040 |
Why?
|
| Biometry | 2 | 2015 | 13 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2022 | 100 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 134 | 0.040 |
Why?
|
| Random Allocation | 1 | 2002 | 200 | 0.040 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2021 | 2 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2021 | 24 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 204 | 0.040 |
Why?
|
| SMARCB1 Protein | 1 | 2021 | 13 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 12 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 252 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2003 | 223 | 0.040 |
Why?
|
| Chromosome Structures | 1 | 2020 | 7 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 799 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2020 | 20 | 0.040 |
Why?
|
| Mice | 3 | 2022 | 11185 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 64 | 0.040 |
Why?
|
| RNA, Small Nuclear | 1 | 2020 | 25 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2021 | 200 | 0.040 |
Why?
|
| Wakefulness | 2 | 2011 | 45 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 99 | 0.040 |
Why?
|
| Cysteine | 1 | 2021 | 108 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 132 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 89 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 176 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 82 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 404 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 29 | 0.040 |
Why?
|
| Cholesterol | 1 | 2021 | 262 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 200 | 0.040 |
Why?
|
| Psychopathology | 1 | 2019 | 22 | 0.040 |
Why?
|
| Stroop Test | 1 | 2019 | 8 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 667 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 405 | 0.040 |
Why?
|
| Functional Neuroimaging | 1 | 2019 | 18 | 0.040 |
Why?
|
| Ethanol | 1 | 2022 | 333 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2018 | 19 | 0.040 |
Why?
|
| Automation | 1 | 2018 | 55 | 0.040 |
Why?
|
| Lod Score | 2 | 2008 | 23 | 0.040 |
Why?
|
| Cancer Survivors | 1 | 2021 | 130 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 485 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 432 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1980 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 1029 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 219 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2018 | 141 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 26 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 856 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2008 | 17 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 108 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2018 | 85 | 0.030 |
Why?
|
| Health Promotion | 1 | 2022 | 523 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 387 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 527 | 0.030 |
Why?
|
| Culture | 1 | 2017 | 82 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2015 | 5834 | 0.030 |
Why?
|
| China | 2 | 2008 | 181 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2031 | 0.030 |
Why?
|
| Psychomotor Performance | 2 | 2011 | 139 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 634 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 274 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 413 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2401 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 1635 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2015 | 47 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 408 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 71 | 0.030 |
Why?
|
| Fasting | 1 | 2015 | 52 | 0.030 |
Why?
|
| E2F3 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| SOXC Transcription Factors | 1 | 2015 | 9 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 181 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2015 | 27 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 806 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1172 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1719 | 0.030 |
Why?
|
| Occupations | 1 | 2014 | 52 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Heredity | 1 | 2014 | 6 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 1583 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2194 | 0.030 |
Why?
|
| Triglycerides | 1 | 2015 | 249 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2013 | 9 | 0.030 |
Why?
|
| Neocortex | 1 | 2013 | 15 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2013 | 10 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 579 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 417 | 0.020 |
Why?
|
| Cultural Deprivation | 1 | 2013 | 1 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 186 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 35 | 0.020 |
Why?
|
| International Agencies | 1 | 2012 | 7 | 0.020 |
Why?
|
| Lipids | 1 | 2015 | 331 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2015 | 502 | 0.020 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 22 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2014 | 210 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 217 | 0.020 |
Why?
|
| Loneliness | 1 | 2012 | 20 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 1332 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 462 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 488 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 312 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 3170 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 415 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 195 | 0.020 |
Why?
|
| Personality | 1 | 2012 | 29 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 697 | 0.020 |
Why?
|
| Ear | 1 | 2011 | 9 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2011 | 21 | 0.020 |
Why?
|
| Hypoparathyroidism | 1 | 2011 | 8 | 0.020 |
Why?
|
| Nose | 1 | 2011 | 27 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2011 | 20 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 91 | 0.020 |
Why?
|
| Marriage | 1 | 2011 | 23 | 0.020 |
Why?
|
| Japan | 1 | 2010 | 67 | 0.020 |
Why?
|
| Social Identification | 1 | 2010 | 18 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 101 | 0.020 |
Why?
|
| Social Perception | 1 | 2010 | 44 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 63 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 67 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 79 | 0.020 |
Why?
|
| Aggression | 1 | 2010 | 79 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 969 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 926 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2008 | 21 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 190 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 52 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2008 | 46 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2008 | 124 | 0.020 |
Why?
|
| Chilblains | 1 | 2007 | 1 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 2007 | 4 | 0.020 |
Why?
|
| Ribonuclease H | 1 | 2007 | 19 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 29 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 69 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2007 | 79 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 198 | 0.020 |
Why?
|
| Calcinosis | 1 | 2007 | 84 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2007 | 137 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2007 | 224 | 0.010 |
Why?
|
| Military Medicine | 1 | 2006 | 32 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 1433 | 0.010 |
Why?
|
| Paranoid Disorders | 1 | 2005 | 2 | 0.010 |
Why?
|
| Creativity | 1 | 2005 | 14 | 0.010 |
Why?
|
| Confusion | 1 | 2005 | 16 | 0.010 |
Why?
|
| Intention | 1 | 2006 | 74 | 0.010 |
Why?
|
| Dyspepsia | 1 | 2005 | 2 | 0.010 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2005 | 9 | 0.010 |
Why?
|
| Fibromyalgia | 1 | 2005 | 15 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2005 | 28 | 0.010 |
Why?
|
| Bias | 1 | 2005 | 117 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 213 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2005 | 130 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2005 | 82 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 922 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 899 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 208 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 9 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2004 | 535 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 853 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 2002 | 17 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2002 | 306 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 1404 | 0.010 |
Why?
|